MSD Signs a Multiyear Agreement with Just – Evotec Biologics for Gaining Access to J.POD Facility

Shots:

• Just-Evotec to receive $15M up front, milestones on completion of the construction of the J.POD facility (facility of the future) as well as a broad collaboration around reserved capacities
• Just – Evotec Biologics granted MSD access to manufacturing capacity in the J.POD facility in Redmond, Washington, which was co-developed by MSD and Just Biotherapeutics under 2015 agreement
• J.POD (manufacturing and plant design) is an integral part of the Just – Evotec Biologics’ J.DESIGN platform that integrates data analytics & ML through all activities involved in the development of biologics

Click here to­ read full press release/ article | Ref: Evotec | Image: Just Biotherapeutics